基因治疗

克服基于寡核苷酸的疗法的生物分析挑战以及与临床开发计划的相关性
“Gene therapy provides the hope of actual cures. These therapies still have many challenges to overcome before they will become widely developed therapeutic options.” Featuring Frontage's Chief Business Officer, Hugh Davis, and Vice President of Biologics Services, Weiping Shao